tiprankstipranks
Trending News
More News >
Immix Biopharma, Inc. (IMMX)
:IMMX
US Market

Immix Biopharma (IMMX) Income Statement

Compare
136 Followers

Immix Biopharma Income Statement

Last quarter (Q4 2024), Immix Biopharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Immix Biopharma's net income was $-4.81M. See Immix Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ -89.52M$ 0.00$ 0.00
Gross Profit
$ 0.00$ -5.47K$ -89.52M$ -2.47K$ -2.32K
Operating Expenses
$ 22.67M$ 16.14M$ 8.22M$ 1.35M$ 453.85K
Depreciation and Amortization
$ 0.00$ 5.47K$ 2.13K$ 2.47K$ 2.32K
EBITDA
$ -22.67M$ -16.14M$ -8.22M$ -1.35M$ -451.53K
Operating Income
$ -22.67M$ -16.14M$ -8.22M$ -1.35M$ -453.85K
Other Income/Expenses
$ 1.02M$ 572.01K$ -497.00$ -23.03M$ -676.46K
Pretax Income
$ -21.66M$ -15.57M$ -8.22M$ -24.38M$ -1.13M
Net Income
$ -21.61M$ -15.43M$ -8.23M$ -24.38M$ -1.15M
Per Share Metrics
Basic EPS
$ -0.76$ -0.89$ -0.62$ -1.84$ -0.15
Diluted EPS
$ -0.76$ -0.89$ -0.62$ -1.84$ -0.15
Weighted Average Shares Outstanding
28.29M 17.34M 13.23M 13.23M 7.77M
Weighted Average Shares Outstanding (Diluted)
28.29M 17.34M 13.23M 13.23M 7.77M
Currency in USD

Immix Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis